Clinical trials
COVID-19 clinical trials
Below are recruiting covid-19 clinical trials, each written for real people, not researchers. We’re tracking 273 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06667700RecruitingPhase 3
A study of the antiviral molnupiravir for high-risk people with COVID-19
This study tests an antiviral pill called molnupiravir to see if it can prevent severe COVID-19 in people who are at high risk and cannot take Paxlovid. If you have mild to moderate COVID-19 symptoms and certain health risks, you may be able to join.
Cullman, AlabamaAges 18 years+ - NCT06883513Recruiting
Osteopathic therapy for long COVID symptoms
This trial tests if gentle hands-on treatment (osteopathic manipulative therapy) can help relieve long-lasting COVID symptoms like fatigue, brain fog, and body pain.
Louisville, KentuckyAges 18 years+ - NCT07464314RecruitingPhase 1
Testing a combined flu and COVID-19 mRNA vaccine in older adults
This trial is testing whether a new mRNA vaccine that targets both seasonal flu and COVID-19 is safe and creates a strong immune response. It may offer an easier way to protect against two illnesses with one shot.
Anniston, AlabamaAges 65–85 - NCT06469788Recruiting
COVID-19 vaccine navigation for rheumatology patients
This study looks at helping Black and Latinx adults with autoimmune rheumatic diseases get the updated COVID-19 vaccine. It offers information and support (like testimonials and navigation help) to see what works best.
Birmingham, AlabamaAges 18 years+ - NCT04169542Recruiting
Study on how COVID-19 affected costs for breast surgery patients
This study asks people with breast cancer who are having breast surgery about how COVID-19 affected their out-of-pocket costs, work income, and job stability. Your answers may help improve support for patients during public health emergencies.
Conroe, TexasAges 18 years+ - NCT07157007RecruitingPhase 2
Testing a New COVID-19 Drug for Mild to Moderate Cases
This trial tests a new drug, ratutrelvir, for people with mild to moderate COVID-19. It aims to find a safe and effective dose to help you feel better faster.
Charlestown, New South WalesAges 18 years+ - NCT04746183RecruitingPhase 1/Phase 2
Early trial testing treatments for COVID-19 in the first days
This early-stage study tests COVID-19 treatments in people who have recently developed symptoms and who test positive for the virus. It aims to find safer, more effective options for preventing worsening disease, especially in higher-risk groups.
Cape TownAges 18 years+ - NCT04362150Recruiting
Study of long-term effects after COVID-19 infection
This study follows adults who had COVID-19 to learn how the illness can affect health over the long term. It may help researchers understand lasting symptoms and who is at higher risk, which could improve future care.
San Francisco, CaliforniaAges 18–100 - NCT04382846RecruitingPhase 3
Testing new treatment combinations for COVID-19
This trial studies new drug treatment plans for people who currently have COVID-19. If it works better than standard care, it could improve recovery for patients.
TantaAges 18 years+ - NCT04351347RecruitingPhase 2/Phase 3
Testing higher-dose ivermectin for COVID-19
This trial studies whether a higher dose of ivermectin helps people with COVID-19. It looks at how well the treatment works and whether it causes side effects for participants.
TantaAges Any age - NCT06311435Recruiting
Blood test for long COVID diagnosis
This study is testing a new blood test that looks for specific RNA markers to help diagnose long COVID. If you have new, lasting symptoms after a confirmed COVID-19 infection, this study may help find answers.
Iowa City, IowaAges 18 years+ - NCT06355258RecruitingPhase 1
Troxerutin to prevent blood clots in COVID-19 patients
This trial tests if the drug troxerutin can prevent dangerous blood clots in adults hospitalized with mild or severe COVID-19. If you have COVID-19 and are not already on blood thinners or at high risk for bleeding, you may be able to join.
Shaoxing, ZhejiangAges 18 years+ - NCT04790240RecruitingPhase 1/Phase 2
Herbal treatment aimed to reduce COVID-19 inflammation
This early-stage trial studies whether certain medical herbs can lower inflammation in people with recent COVID-19 and help the immune system better fight the virus. You may be able to join whether or not you take standard COVID medicines, but you would need to complete the herb plan and provide specific lab and scan results.
Rockville, MarylandAges Any age - NCT07108036RecruitingPhase 2
Testing Anktiva for Long COVID Symptoms
This trial tests a medicine called Anktiva to see if it can help people with Long COVID. It's for adults who had a confirmed COVID-19 infection and now have lasting symptoms like fatigue, brain fog, or trouble breathing.
San Francisco, CaliforniaAges 18–70 - NCT06511063RecruitingPhase 2
Antiviral trial for treating long covid symptoms
This study tests whether antiviral drugs (Truvada and Selzentry) can help people with long COVID. You may qualify if you have had long COVID symptoms for at least 6 months, including fatigue and post-exertional malaise.
New York, New YorkAges 18 years+ - NCT06142253Recruiting
Water exercise for long COVID brain fog
This study tests whether water-based exercise (like swimming or water aerobics) helps veterans recover from long COVID, especially brain fog and memory problems. If you're a veteran with ongoing thinking issues after COVID-19, this may help you improve your symptoms over 8 months.
Palo Alto, CaliforniaAges 18–89 - NCT06086366Recruiting
Brain scan study for depression after COVID-19
This study uses brain scans to understand depression that starts soon after COVID-19. Researchers want to see if there are changes in brain chemistry related to depression, and you may help find new treatment targets.
Toronto, OntarioAges 18–75 - NCT07278206Recruiting
Brain stimulation for long COVID fatigue and brain fog
This trial tests whether a non-invasive brain treatment called rTMS (repetitive transcranial magnetic stimulation) can help with the severe fatigue and brain fog that often come with long COVID. You would need to be able to come to the hospital for multiple treatment sessions.
AmsterdamAges 18 years+ - NCT06633666Recruiting
Acupuncture for Long COVID brain and mood symptoms
This study tests whether acupuncture can help with brain fog, memory problems, depression, or anxiety that started after COVID-19 and won't go away. If you have Long COVID and these symptoms, acupuncture might offer relief.
Kowloon Tong, KowloonAges 18–80 - NCT06928116Recruiting
Heat therapy and exercise for COVID-19 recovery
This study tests whether heat therapy (using warm temperatures) combined with a leg exercise program can help improve fatigue and physical function in people who have had COVID-19 and still feel symptoms like tiredness or reduced mobility.
Omaha, NebraskaAges 50–90 - NCT05188612Recruiting
Hospital patients with confirmed COVID-19 survey study
This study collects information from adults who are in the hospital for confirmed COVID-19. The goal is to better understand what happens during acute (early) COVID-19 and improve care.
Bologna, BolognaAges 18 years+ - NCT07156994Recruiting
Voice study for Long COVID symptoms
This study uses voice recordings from the Long COVID Companion App to find patterns that could help identify and monitor Long COVID symptoms. It may help improve how we detect and track COVID-19-related health issues using just your voice.
StrassenAges 18 years+ - NCT07781501Recruiting
Study of long-term effects of covid-19
This study looks at the long-term effects of COVID-19, sometimes called Long COVID. By studying saliva and health info, researchers hope to understand why some people have lasting symptoms.
Chapel Hill, North CarolinaAges 18–75 - NCT07504341Recruiting
Managing COVID-19 with vital signs
This trial looks at how patients' basic health signs like blood pressure and breathing rate affect their COVID-19 treatment. Doctors will review hospital records from a specific time period to learn more.
Chiayi CityAges Any age
Hear when a new COVID-19 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for covid-19?
- Yes. Clin2 currently lists 273 recruiting covid-19 studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a covid-19 trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a covid-19 trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.